nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—SLC22A6—Pravastatin—atherosclerosis	0.162	0.418	CbGbCtD
Acetazolamide—CYP3A4—Ezetimibe—atherosclerosis	0.0474	0.123	CbGbCtD
Acetazolamide—CYP3A4—Rosuvastatin—atherosclerosis	0.0474	0.123	CbGbCtD
Acetazolamide—CYP3A4—Simvastatin—atherosclerosis	0.0441	0.114	CbGbCtD
Acetazolamide—CYP3A4—Pravastatin—atherosclerosis	0.0432	0.112	CbGbCtD
Acetazolamide—CYP3A4—Lovastatin—atherosclerosis	0.0432	0.112	CbGbCtD
Acetazolamide—AQP1—endothelium—atherosclerosis	0.0127	0.149	CbGeAlD
Acetazolamide—AQP1—blood vessel—atherosclerosis	0.0118	0.137	CbGeAlD
Acetazolamide—Hepatic necrosis—Lovastatin—atherosclerosis	0.00862	0.0246	CcSEcCtD
Acetazolamide—Hepatic necrosis—Simvastatin—atherosclerosis	0.00807	0.023	CcSEcCtD
Acetazolamide—Hepatic necrosis—Pravastatin—atherosclerosis	0.00729	0.0208	CcSEcCtD
Acetazolamide—Blood disorder—Rosuvastatin—atherosclerosis	0.00708	0.0202	CcSEcCtD
Acetazolamide—AQP1—connective tissue—atherosclerosis	0.00603	0.0703	CbGeAlD
Acetazolamide—Jaundice cholestatic—Lovastatin—atherosclerosis	0.0057	0.0163	CcSEcCtD
Acetazolamide—Tingling sensation—Niacin—atherosclerosis	0.00536	0.0153	CcSEcCtD
Acetazolamide—Jaundice cholestatic—Simvastatin—atherosclerosis	0.00534	0.0152	CcSEcCtD
Acetazolamide—AQP1—cardiovascular system—atherosclerosis	0.00525	0.0612	CbGeAlD
Acetazolamide—Numbness—Pravastatin—atherosclerosis	0.00511	0.0146	CcSEcCtD
Acetazolamide—Jaundice cholestatic—Niacin—atherosclerosis	0.0049	0.014	CcSEcCtD
Acetazolamide—Sensory loss—Pravastatin—atherosclerosis	0.00489	0.0139	CcSEcCtD
Acetazolamide—Jaundice cholestatic—Pravastatin—atherosclerosis	0.00482	0.0137	CcSEcCtD
Acetazolamide—Hepatic failure—Rosuvastatin—atherosclerosis	0.00478	0.0136	CcSEcCtD
Acetazolamide—AQP1—adipose tissue—atherosclerosis	0.00463	0.054	CbGeAlD
Acetazolamide—CA3—connective tissue—atherosclerosis	0.00442	0.0516	CbGeAlD
Acetazolamide—Hepatic function abnormal—Lovastatin—atherosclerosis	0.00416	0.0119	CcSEcCtD
Acetazolamide—Photosensitivity—Lovastatin—atherosclerosis	0.00414	0.0118	CcSEcCtD
Acetazolamide—Photosensitivity—Ezetimibe—atherosclerosis	0.00406	0.0116	CcSEcCtD
Acetazolamide—Hepatic failure—Lovastatin—atherosclerosis	0.00405	0.0115	CcSEcCtD
Acetazolamide—Hepatic failure—Ezetimibe—atherosclerosis	0.00397	0.0113	CcSEcCtD
Acetazolamide—CA5A—liver—atherosclerosis	0.0039	0.0455	CbGeAlD
Acetazolamide—Hepatic function abnormal—Simvastatin—atherosclerosis	0.00389	0.0111	CcSEcCtD
Acetazolamide—Urine output increased—Niacin—atherosclerosis	0.00389	0.0111	CcSEcCtD
Acetazolamide—Photosensitivity—Simvastatin—atherosclerosis	0.00388	0.011	CcSEcCtD
Acetazolamide—CA3—cardiovascular system—atherosclerosis	0.00385	0.0449	CbGeAlD
Acetazolamide—Hepatic failure—Simvastatin—atherosclerosis	0.00379	0.0108	CcSEcCtD
Acetazolamide—Hepatic function abnormal—Niacin—atherosclerosis	0.00358	0.0102	CcSEcCtD
Acetazolamide—Polyuria—Niacin—atherosclerosis	0.00356	0.0101	CcSEcCtD
Acetazolamide—Hepatic function abnormal—Pravastatin—atherosclerosis	0.00352	0.01	CcSEcCtD
Acetazolamide—Photosensitivity—Pravastatin—atherosclerosis	0.0035	0.00999	CcSEcCtD
Acetazolamide—Hepatic failure—Pravastatin—atherosclerosis	0.00342	0.00976	CcSEcCtD
Acetazolamide—CA3—adipose tissue—atherosclerosis	0.00339	0.0396	CbGeAlD
Acetazolamide—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.00328	0.00934	CcSEcCtD
Acetazolamide—AQP1—liver—atherosclerosis	0.00324	0.0378	CbGeAlD
Acetazolamide—Haematuria—Rosuvastatin—atherosclerosis	0.00315	0.00899	CcSEcCtD
Acetazolamide—CA12—connective tissue—atherosclerosis	0.00313	0.0365	CbGeAlD
Acetazolamide—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00313	0.00892	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.00306	0.00873	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Lovastatin—atherosclerosis	0.00287	0.00818	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.00282	0.00802	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.00278	0.00792	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.00277	0.0079	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Simvastatin—atherosclerosis	0.00268	0.00765	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.0026	0.00741	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.0026	0.00741	CcSEcCtD
Acetazolamide—CA5B—cardiovascular system—atherosclerosis	0.00244	0.0285	CbGeAlD
Acetazolamide—Photosensitivity reaction—Pravastatin—atherosclerosis	0.00243	0.00692	CcSEcCtD
Acetazolamide—Erythema multiforme—Lovastatin—atherosclerosis	0.00238	0.00678	CcSEcCtD
Acetazolamide—CA3—liver—atherosclerosis	0.00238	0.0278	CbGeAlD
Acetazolamide—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00235	0.0067	CcSEcCtD
Acetazolamide—Flushing—Lovastatin—atherosclerosis	0.00234	0.00666	CcSEcCtD
Acetazolamide—Erythema multiforme—Ezetimibe—atherosclerosis	0.00233	0.00665	CcSEcCtD
Acetazolamide—Flushing—Ezetimibe—atherosclerosis	0.00229	0.00653	CcSEcCtD
Acetazolamide—Erythema multiforme—Simvastatin—atherosclerosis	0.00223	0.00634	CcSEcCtD
Acetazolamide—Flushing—Simvastatin—atherosclerosis	0.00218	0.00623	CcSEcCtD
Acetazolamide—CA14—liver—atherosclerosis	0.00216	0.0252	CbGeAlD
Acetazolamide—CA1—cardiovascular system—atherosclerosis	0.00216	0.0252	CbGeAlD
Acetazolamide—CA5B—adipose tissue—atherosclerosis	0.00215	0.0251	CbGeAlD
Acetazolamide—Hypoaesthesia—Niacin—atherosclerosis	0.00215	0.00613	CcSEcCtD
Acetazolamide—Dysgeusia—Lovastatin—atherosclerosis	0.00215	0.00611	CcSEcCtD
Acetazolamide—Confusional state—Rosuvastatin—atherosclerosis	0.00213	0.00606	CcSEcCtD
Acetazolamide—Hypoaesthesia—Pravastatin—atherosclerosis	0.00212	0.00604	CcSEcCtD
Acetazolamide—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00207	0.00589	CcSEcCtD
Acetazolamide—Ill-defined disorder—Lovastatin—atherosclerosis	0.00203	0.00579	CcSEcCtD
Acetazolamide—Tinnitus—Niacin—atherosclerosis	0.00202	0.00574	CcSEcCtD
Acetazolamide—Erythema multiforme—Pravastatin—atherosclerosis	0.00201	0.00574	CcSEcCtD
Acetazolamide—Dysgeusia—Simvastatin—atherosclerosis	0.00201	0.00572	CcSEcCtD
Acetazolamide—Flushing—Niacin—atherosclerosis	0.00201	0.00572	CcSEcCtD
Acetazolamide—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00199	0.00568	CcSEcCtD
Acetazolamide—Tinnitus—Pravastatin—atherosclerosis	0.00198	0.00566	CcSEcCtD
Acetazolamide—Malaise—Lovastatin—atherosclerosis	0.00198	0.00563	CcSEcCtD
Acetazolamide—Flushing—Pravastatin—atherosclerosis	0.00198	0.00563	CcSEcCtD
Acetazolamide—Leukopenia—Lovastatin—atherosclerosis	0.00196	0.00559	CcSEcCtD
Acetazolamide—Malaise—Ezetimibe—atherosclerosis	0.00194	0.00552	CcSEcCtD
Acetazolamide—CA1—adipose tissue—atherosclerosis	0.0019	0.0222	CbGeAlD
Acetazolamide—Ill-defined disorder—Simvastatin—atherosclerosis	0.0019	0.00542	CcSEcCtD
Acetazolamide—Paraesthesia—Rosuvastatin—atherosclerosis	0.00189	0.0054	CcSEcCtD
Acetazolamide—Dyspepsia—Rosuvastatin—atherosclerosis	0.00186	0.00529	CcSEcCtD
Acetazolamide—Malaise—Simvastatin—atherosclerosis	0.00185	0.00527	CcSEcCtD
Acetazolamide—Discomfort—Lovastatin—atherosclerosis	0.00184	0.00525	CcSEcCtD
Acetazolamide—Leukopenia—Simvastatin—atherosclerosis	0.00183	0.00523	CcSEcCtD
Acetazolamide—Dysgeusia—Pravastatin—atherosclerosis	0.00181	0.00517	CcSEcCtD
Acetazolamide—Discomfort—Ezetimibe—atherosclerosis	0.00181	0.00515	CcSEcCtD
Acetazolamide—Confusional state—Lovastatin—atherosclerosis	0.0018	0.00514	CcSEcCtD
Acetazolamide—Anaphylactic shock—Lovastatin—atherosclerosis	0.00179	0.0051	CcSEcCtD
Acetazolamide—Confusional state—Ezetimibe—atherosclerosis	0.00177	0.00504	CcSEcCtD
Acetazolamide—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00175	0.005	CcSEcCtD
Acetazolamide—Thrombocytopenia—Lovastatin—atherosclerosis	0.00175	0.00499	CcSEcCtD
Acetazolamide—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00174	0.00496	CcSEcCtD
Acetazolamide—Discomfort—Simvastatin—atherosclerosis	0.00172	0.00491	CcSEcCtD
Acetazolamide—Ill-defined disorder—Pravastatin—atherosclerosis	0.00172	0.0049	CcSEcCtD
Acetazolamide—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00172	0.00489	CcSEcCtD
Acetazolamide—CA4—cardiovascular system—atherosclerosis	0.00169	0.0197	CbGeAlD
Acetazolamide—Confusional state—Simvastatin—atherosclerosis	0.00169	0.00481	CcSEcCtD
Acetazolamide—Leukopenia—Niacin—atherosclerosis	0.00168	0.0048	CcSEcCtD
Acetazolamide—Urticaria—Rosuvastatin—atherosclerosis	0.00168	0.00478	CcSEcCtD
Acetazolamide—Anaphylactic shock—Simvastatin—atherosclerosis	0.00167	0.00477	CcSEcCtD
Acetazolamide—Malaise—Pravastatin—atherosclerosis	0.00167	0.00476	CcSEcCtD
Acetazolamide—Leukopenia—Pravastatin—atherosclerosis	0.00166	0.00473	CcSEcCtD
Acetazolamide—Thrombocytopenia—Simvastatin—atherosclerosis	0.00164	0.00467	CcSEcCtD
Acetazolamide—CA2—connective tissue—atherosclerosis	0.00161	0.0188	CbGeAlD
Acetazolamide—Paraesthesia—Lovastatin—atherosclerosis	0.00161	0.00458	CcSEcCtD
Acetazolamide—Paraesthesia—Ezetimibe—atherosclerosis	0.00157	0.00449	CcSEcCtD
Acetazolamide—Dyspepsia—Lovastatin—atherosclerosis	0.00157	0.00449	CcSEcCtD
Acetazolamide—Discomfort—Pravastatin—atherosclerosis	0.00156	0.00444	CcSEcCtD
Acetazolamide—Decreased appetite—Lovastatin—atherosclerosis	0.00155	0.00443	CcSEcCtD
Acetazolamide—Dyspepsia—Ezetimibe—atherosclerosis	0.00154	0.0044	CcSEcCtD
Acetazolamide—Fatigue—Lovastatin—atherosclerosis	0.00154	0.00439	CcSEcCtD
Acetazolamide—Anaphylactic shock—Niacin—atherosclerosis	0.00154	0.00438	CcSEcCtD
Acetazolamide—Confusional state—Pravastatin—atherosclerosis	0.00152	0.00435	CcSEcCtD
Acetazolamide—Decreased appetite—Ezetimibe—atherosclerosis	0.00152	0.00435	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00151	0.00432	CcSEcCtD
Acetazolamide—Asthenia—Rosuvastatin—atherosclerosis	0.00151	0.00431	CcSEcCtD
Acetazolamide—Anaphylactic shock—Pravastatin—atherosclerosis	0.00151	0.00431	CcSEcCtD
Acetazolamide—Fatigue—Ezetimibe—atherosclerosis	0.00151	0.00431	CcSEcCtD
Acetazolamide—Shock—Niacin—atherosclerosis	0.00151	0.00431	CcSEcCtD
Acetazolamide—Paraesthesia—Simvastatin—atherosclerosis	0.0015	0.00428	CcSEcCtD
Acetazolamide—CA4—adipose tissue—atherosclerosis	0.00149	0.0174	CbGeAlD
Acetazolamide—Thrombocytopenia—Pravastatin—atherosclerosis	0.00148	0.00422	CcSEcCtD
Acetazolamide—Feeling abnormal—Lovastatin—atherosclerosis	0.00147	0.0042	CcSEcCtD
Acetazolamide—Dyspepsia—Simvastatin—atherosclerosis	0.00147	0.0042	CcSEcCtD
Acetazolamide—Decreased appetite—Simvastatin—atherosclerosis	0.00145	0.00414	CcSEcCtD
Acetazolamide—Feeling abnormal—Ezetimibe—atherosclerosis	0.00145	0.00412	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00144	0.00412	CcSEcCtD
Acetazolamide—Diarrhoea—Rosuvastatin—atherosclerosis	0.00144	0.00411	CcSEcCtD
Acetazolamide—Fatigue—Simvastatin—atherosclerosis	0.00144	0.00411	CcSEcCtD
Acetazolamide—Urticaria—Lovastatin—atherosclerosis	0.00142	0.00405	CcSEcCtD
Acetazolamide—Body temperature increased—Lovastatin—atherosclerosis	0.00141	0.00403	CcSEcCtD
Acetazolamide—CA2—cardiovascular system—atherosclerosis	0.0014	0.0163	CbGeAlD
Acetazolamide—Dizziness—Rosuvastatin—atherosclerosis	0.0014	0.00398	CcSEcCtD
Acetazolamide—Urticaria—Ezetimibe—atherosclerosis	0.00139	0.00397	CcSEcCtD
Acetazolamide—Body temperature increased—Ezetimibe—atherosclerosis	0.00139	0.00395	CcSEcCtD
Acetazolamide—Paraesthesia—Niacin—atherosclerosis	0.00138	0.00393	CcSEcCtD
Acetazolamide—Feeling abnormal—Simvastatin—atherosclerosis	0.00138	0.00393	CcSEcCtD
Acetazolamide—Somnolence—Niacin—atherosclerosis	0.00137	0.00389	CcSEcCtD
Acetazolamide—Paraesthesia—Pravastatin—atherosclerosis	0.00136	0.00387	CcSEcCtD
Acetazolamide—Dyspepsia—Niacin—atherosclerosis	0.00135	0.00385	CcSEcCtD
Acetazolamide—Decreased appetite—Niacin—atherosclerosis	0.00134	0.0038	CcSEcCtD
Acetazolamide—CA1—liver—atherosclerosis	0.00133	0.0156	CbGeAlD
Acetazolamide—Dyspepsia—Pravastatin—atherosclerosis	0.00133	0.00379	CcSEcCtD
Acetazolamide—Urticaria—Simvastatin—atherosclerosis	0.00133	0.00379	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Niacin—atherosclerosis	0.00133	0.00378	CcSEcCtD
Acetazolamide—Body temperature increased—Simvastatin—atherosclerosis	0.00132	0.00377	CcSEcCtD
Acetazolamide—Headache—Rosuvastatin—atherosclerosis	0.00132	0.00377	CcSEcCtD
Acetazolamide—Decreased appetite—Pravastatin—atherosclerosis	0.00131	0.00375	CcSEcCtD
Acetazolamide—Fatigue—Pravastatin—atherosclerosis	0.0013	0.00372	CcSEcCtD
Acetazolamide—Asthenia—Lovastatin—atherosclerosis	0.00128	0.00366	CcSEcCtD
Acetazolamide—Asthenia—Ezetimibe—atherosclerosis	0.00126	0.00359	CcSEcCtD
Acetazolamide—Nausea—Rosuvastatin—atherosclerosis	0.00125	0.00357	CcSEcCtD
Acetazolamide—Feeling abnormal—Pravastatin—atherosclerosis	0.00125	0.00355	CcSEcCtD
Acetazolamide—CA2—adipose tissue—atherosclerosis	0.00123	0.0144	CbGeAlD
Acetazolamide—Diarrhoea—Lovastatin—atherosclerosis	0.00122	0.00349	CcSEcCtD
Acetazolamide—Urticaria—Niacin—atherosclerosis	0.00122	0.00348	CcSEcCtD
Acetazolamide—Body temperature increased—Niacin—atherosclerosis	0.00121	0.00346	CcSEcCtD
Acetazolamide—Urticaria—Pravastatin—atherosclerosis	0.0012	0.00342	CcSEcCtD
Acetazolamide—Asthenia—Simvastatin—atherosclerosis	0.0012	0.00342	CcSEcCtD
Acetazolamide—Diarrhoea—Ezetimibe—atherosclerosis	0.0012	0.00342	CcSEcCtD
Acetazolamide—Body temperature increased—Pravastatin—atherosclerosis	0.0012	0.00341	CcSEcCtD
Acetazolamide—Dizziness—Lovastatin—atherosclerosis	0.00118	0.00337	CcSEcCtD
Acetazolamide—Dizziness—Ezetimibe—atherosclerosis	0.00116	0.00331	CcSEcCtD
Acetazolamide—Diarrhoea—Simvastatin—atherosclerosis	0.00114	0.00326	CcSEcCtD
Acetazolamide—Vomiting—Lovastatin—atherosclerosis	0.00114	0.00324	CcSEcCtD
Acetazolamide—Headache—Lovastatin—atherosclerosis	0.00112	0.00319	CcSEcCtD
Acetazolamide—Vomiting—Ezetimibe—atherosclerosis	0.00112	0.00318	CcSEcCtD
Acetazolamide—Dizziness—Simvastatin—atherosclerosis	0.00111	0.00315	CcSEcCtD
Acetazolamide—Asthenia—Niacin—atherosclerosis	0.0011	0.00314	CcSEcCtD
Acetazolamide—Headache—Ezetimibe—atherosclerosis	0.0011	0.00313	CcSEcCtD
Acetazolamide—Asthenia—Pravastatin—atherosclerosis	0.00108	0.00309	CcSEcCtD
Acetazolamide—Vomiting—Simvastatin—atherosclerosis	0.00106	0.00303	CcSEcCtD
Acetazolamide—Nausea—Lovastatin—atherosclerosis	0.00106	0.00303	CcSEcCtD
Acetazolamide—Diarrhoea—Niacin—atherosclerosis	0.00105	0.00299	CcSEcCtD
Acetazolamide—Headache—Simvastatin—atherosclerosis	0.00105	0.00299	CcSEcCtD
Acetazolamide—Nausea—Ezetimibe—atherosclerosis	0.00104	0.00297	CcSEcCtD
Acetazolamide—Diarrhoea—Pravastatin—atherosclerosis	0.00103	0.00295	CcSEcCtD
Acetazolamide—Dizziness—Niacin—atherosclerosis	0.00102	0.00289	CcSEcCtD
Acetazolamide—Dizziness—Pravastatin—atherosclerosis	0.001	0.00285	CcSEcCtD
Acetazolamide—Nausea—Simvastatin—atherosclerosis	0.000993	0.00283	CcSEcCtD
Acetazolamide—Vomiting—Niacin—atherosclerosis	0.000976	0.00278	CcSEcCtD
Acetazolamide—Headache—Niacin—atherosclerosis	0.000962	0.00274	CcSEcCtD
Acetazolamide—Vomiting—Pravastatin—atherosclerosis	0.000961	0.00274	CcSEcCtD
Acetazolamide—Headache—Pravastatin—atherosclerosis	0.000947	0.0027	CcSEcCtD
Acetazolamide—Nausea—Niacin—atherosclerosis	0.000912	0.0026	CcSEcCtD
Acetazolamide—Nausea—Pravastatin—atherosclerosis	0.000898	0.00256	CcSEcCtD
Acetazolamide—CA2—liver—atherosclerosis	0.000865	0.0101	CbGeAlD
Acetazolamide—CYP3A4—liver—atherosclerosis	0.000558	0.00651	CbGeAlD
Acetazolamide—CA4—Metabolism—HMGCR—atherosclerosis	0.000111	0.000632	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—APOB—atherosclerosis	0.000111	0.000627	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—APOB—atherosclerosis	0.000111	0.000627	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—GPX1—atherosclerosis	0.00011	0.000625	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GPX1—atherosclerosis	0.00011	0.000625	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CD36—atherosclerosis	0.00011	0.000625	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—SCARB1—atherosclerosis	0.000109	0.000615	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GSTM1—atherosclerosis	0.000108	0.00061	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GSTM1—atherosclerosis	0.000108	0.00061	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CD36—atherosclerosis	0.000107	0.000609	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CD36—atherosclerosis	0.000107	0.000609	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—HMOX1—atherosclerosis	0.000107	0.000606	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—HMGCR—atherosclerosis	0.000107	0.000606	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—LPL—atherosclerosis	0.000106	0.000598	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—LPL—atherosclerosis	0.000106	0.000598	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—MTHFR—atherosclerosis	0.000104	0.000592	CbGpPWpGaD
Acetazolamide—SLC22A6—SLC-mediated transmembrane transport—ALB—atherosclerosis	0.000104	0.000591	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—NAMPT—atherosclerosis	0.000104	0.000589	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PTGS2—atherosclerosis	0.000103	0.000586	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—LIPC—atherosclerosis	0.000103	0.000585	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GPX1—atherosclerosis	0.000103	0.000584	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GPX1—atherosclerosis	0.000103	0.000584	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—APOC3—atherosclerosis	0.000103	0.000582	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—HMGCR—atherosclerosis	0.000102	0.000581	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PPARA—atherosclerosis	0.000102	0.000581	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—APOB—atherosclerosis	0.000102	0.000581	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—LDLR—atherosclerosis	0.000102	0.000578	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—MTHFR—atherosclerosis	0.000102	0.000577	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—MTHFR—atherosclerosis	0.000102	0.000577	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CD36—atherosclerosis	0.0001	0.000568	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CD36—atherosclerosis	0.0001	0.000568	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PPARA—atherosclerosis	9.99e-05	0.000566	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PPARA—atherosclerosis	9.99e-05	0.000566	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GSTM1—atherosclerosis	9.96e-05	0.000565	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CETP—atherosclerosis	9.96e-05	0.000565	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ABCA1—atherosclerosis	9.94e-05	0.000563	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—AGT—atherosclerosis	9.93e-05	0.000563	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—LPL—atherosclerosis	9.78e-05	0.000554	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—APOE—atherosclerosis	9.72e-05	0.000551	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—AGT—atherosclerosis	9.67e-05	0.000548	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—AGT—atherosclerosis	9.67e-05	0.000548	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CAV1—atherosclerosis	9.64e-05	0.000546	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—APOA1—atherosclerosis	9.61e-05	0.000545	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—PLG—atherosclerosis	9.56e-05	0.000542	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—SCARB1—atherosclerosis	9.54e-05	0.000541	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GPX1—atherosclerosis	9.54e-05	0.000541	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ABCA1—atherosclerosis	9.53e-05	0.00054	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—MTHFR—atherosclerosis	9.5e-05	0.000539	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—MTHFR—atherosclerosis	9.5e-05	0.000539	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—APOE—atherosclerosis	9.48e-05	0.000537	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—APOE—atherosclerosis	9.48e-05	0.000537	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CAV1—atherosclerosis	9.39e-05	0.000532	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CAV1—atherosclerosis	9.39e-05	0.000532	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—APOA1—atherosclerosis	9.37e-05	0.000531	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—APOA1—atherosclerosis	9.37e-05	0.000531	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PPARA—atherosclerosis	9.32e-05	0.000529	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PPARA—atherosclerosis	9.32e-05	0.000529	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CD36—atherosclerosis	9.29e-05	0.000527	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ABCA1—atherosclerosis	9.13e-05	0.000518	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—AGT—atherosclerosis	9.03e-05	0.000512	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—AGT—atherosclerosis	9.03e-05	0.000512	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—HMGCR—atherosclerosis	9.01e-05	0.000511	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—APOE—atherosclerosis	8.85e-05	0.000502	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—APOE—atherosclerosis	8.85e-05	0.000502	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—HMOX1—atherosclerosis	8.82e-05	0.0005	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—MTHFR—atherosclerosis	8.8e-05	0.000499	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PIK3CG—atherosclerosis	8.78e-05	0.000498	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CAV1—atherosclerosis	8.77e-05	0.000497	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CAV1—atherosclerosis	8.77e-05	0.000497	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—APOA1—atherosclerosis	8.75e-05	0.000496	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—APOA1—atherosclerosis	8.75e-05	0.000496	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PPARA—atherosclerosis	8.64e-05	0.00049	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PIK3CG—atherosclerosis	8.55e-05	0.000485	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PIK3CG—atherosclerosis	8.55e-05	0.000485	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—HMOX1—atherosclerosis	8.53e-05	0.000483	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PPARG—atherosclerosis	8.47e-05	0.00048	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—APOB—atherosclerosis	8.45e-05	0.000479	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—AGT—atherosclerosis	8.37e-05	0.000474	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—INS—atherosclerosis	8.31e-05	0.000471	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PPARG—atherosclerosis	8.25e-05	0.000468	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PPARG—atherosclerosis	8.25e-05	0.000468	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—APOE—atherosclerosis	8.2e-05	0.000465	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—IL6—atherosclerosis	8.18e-05	0.000464	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—HMOX1—atherosclerosis	8.17e-05	0.000463	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—APOB—atherosclerosis	8.17e-05	0.000463	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CAV1—atherosclerosis	8.12e-05	0.00046	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—APOA1—atherosclerosis	8.1e-05	0.000459	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—INS—atherosclerosis	8.1e-05	0.000459	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—INS—atherosclerosis	8.1e-05	0.000459	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ABCA1—atherosclerosis	8.03e-05	0.000455	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PIK3CG—atherosclerosis	7.98e-05	0.000453	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PIK3CG—atherosclerosis	7.98e-05	0.000453	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GSTM1—atherosclerosis	7.94e-05	0.00045	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—HMOX1—atherosclerosis	7.84e-05	0.000444	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—APOB—atherosclerosis	7.83e-05	0.000444	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—LPL—atherosclerosis	7.8e-05	0.000442	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PPARG—atherosclerosis	7.71e-05	0.000437	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PPARG—atherosclerosis	7.71e-05	0.000437	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—ALB—atherosclerosis	7.62e-05	0.000432	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GSTM1—atherosclerosis	7.62e-05	0.000432	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GPX1—atherosclerosis	7.61e-05	0.000431	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—INS—atherosclerosis	7.56e-05	0.000428	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—INS—atherosclerosis	7.56e-05	0.000428	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—APOB—atherosclerosis	7.51e-05	0.000426	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—LPL—atherosclerosis	7.48e-05	0.000424	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—ALB—atherosclerosis	7.42e-05	0.000421	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—ALB—atherosclerosis	7.42e-05	0.000421	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CD36—atherosclerosis	7.41e-05	0.00042	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PIK3CG—atherosclerosis	7.4e-05	0.000419	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GSTM1—atherosclerosis	7.3e-05	0.000414	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GPX1—atherosclerosis	7.29e-05	0.000413	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—NOS3—atherosclerosis	7.29e-05	0.000413	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—LPL—atherosclerosis	7.17e-05	0.000406	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PPARG—atherosclerosis	7.14e-05	0.000405	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—PPARA—atherosclerosis	7.13e-05	0.000404	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CD36—atherosclerosis	7.1e-05	0.000403	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—NOS3—atherosclerosis	7.1e-05	0.000402	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—NOS3—atherosclerosis	7.1e-05	0.000402	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—MTHFR—atherosclerosis	7.02e-05	0.000398	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—INS—atherosclerosis	7e-05	0.000397	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GPX1—atherosclerosis	6.99e-05	0.000396	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—ALB—atherosclerosis	6.93e-05	0.000393	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—ALB—atherosclerosis	6.93e-05	0.000393	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—HMOX1—atherosclerosis	6.89e-05	0.000391	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PPARA—atherosclerosis	6.89e-05	0.00039	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CD36—atherosclerosis	6.81e-05	0.000386	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—MTHFR—atherosclerosis	6.73e-05	0.000382	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—APOA1—atherosclerosis	6.69e-05	0.000379	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—AGT—atherosclerosis	6.67e-05	0.000378	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PTGS2—atherosclerosis	6.66e-05	0.000378	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—NOS3—atherosclerosis	6.63e-05	0.000376	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—NOS3—atherosclerosis	6.63e-05	0.000376	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PPARA—atherosclerosis	6.6e-05	0.000374	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—APOB—atherosclerosis	6.6e-05	0.000374	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—APOE—atherosclerosis	6.54e-05	0.000371	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PTGS2—atherosclerosis	6.49e-05	0.000368	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PTGS2—atherosclerosis	6.49e-05	0.000368	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CAV1—atherosclerosis	6.48e-05	0.000367	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—APOA1—atherosclerosis	6.46e-05	0.000366	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—MTHFR—atherosclerosis	6.45e-05	0.000366	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GSTM1—atherosclerosis	6.42e-05	0.000364	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—ALB—atherosclerosis	6.42e-05	0.000364	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—AGT—atherosclerosis	6.4e-05	0.000363	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PPARA—atherosclerosis	6.33e-05	0.000359	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	6.32e-05	0.000358	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—LPL—atherosclerosis	6.3e-05	0.000357	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—APOE—atherosclerosis	6.27e-05	0.000355	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	6.23e-05	0.000353	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CAV1—atherosclerosis	6.21e-05	0.000352	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—APOA1—atherosclerosis	6.19e-05	0.000351	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GPX1—atherosclerosis	6.15e-05	0.000348	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—NOS3—atherosclerosis	6.14e-05	0.000348	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—AGT—atherosclerosis	6.13e-05	0.000348	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PTGS2—atherosclerosis	6.06e-05	0.000344	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PTGS2—atherosclerosis	6.06e-05	0.000344	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—APOE—atherosclerosis	6.01e-05	0.000341	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—AKT1—atherosclerosis	5.99e-05	0.00034	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CD36—atherosclerosis	5.99e-05	0.000339	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CAV1—atherosclerosis	5.95e-05	0.000337	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—APOA1—atherosclerosis	5.94e-05	0.000337	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PIK3CG—atherosclerosis	5.9e-05	0.000334	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PPARG—atherosclerosis	5.69e-05	0.000323	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—MTHFR—atherosclerosis	5.67e-05	0.000322	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PIK3CG—atherosclerosis	5.66e-05	0.000321	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PTGS2—atherosclerosis	5.62e-05	0.000318	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—INS—atherosclerosis	5.58e-05	0.000317	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PPARA—atherosclerosis	5.57e-05	0.000316	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PPARG—atherosclerosis	5.46e-05	0.000309	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PIK3CG—atherosclerosis	5.42e-05	0.000307	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—AGT—atherosclerosis	5.39e-05	0.000306	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—INS—atherosclerosis	5.35e-05	0.000303	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—ALB—atherosclerosis	5.3e-05	0.0003	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—APOE—atherosclerosis	5.28e-05	0.000299	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CAV1—atherosclerosis	5.23e-05	0.000297	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PPARG—atherosclerosis	5.23e-05	0.000297	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—APOA1—atherosclerosis	5.22e-05	0.000296	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—AKT1—atherosclerosis	5.2e-05	0.000295	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—INS—atherosclerosis	5.13e-05	0.000291	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ALB—atherosclerosis	5.12e-05	0.00029	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ALB—atherosclerosis	4.91e-05	0.000278	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—NOS3—atherosclerosis	4.9e-05	0.000278	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PIK3CG—atherosclerosis	4.77e-05	0.00027	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ALB—atherosclerosis	4.71e-05	0.000267	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—NOS3—atherosclerosis	4.69e-05	0.000266	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PPARG—atherosclerosis	4.6e-05	0.000261	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—INS—atherosclerosis	4.51e-05	0.000256	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—NOS3—atherosclerosis	4.5e-05	0.000255	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	4.48e-05	0.000254	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PTGS2—atherosclerosis	4.48e-05	0.000254	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PTGS2—atherosclerosis	4.29e-05	0.000243	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PLTP—atherosclerosis	4.21e-05	0.000239	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ALB—atherosclerosis	4.14e-05	0.000234	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PTGS2—atherosclerosis	4.12e-05	0.000233	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—NOS3—atherosclerosis	3.96e-05	0.000224	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—LTA4H—atherosclerosis	3.65e-05	0.000207	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ABCG8—atherosclerosis	3.65e-05	0.000207	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PTGS2—atherosclerosis	3.62e-05	0.000205	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—AKT1—atherosclerosis	3.35e-05	0.00019	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—AKT1—atherosclerosis	3.26e-05	0.000185	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—AKT1—atherosclerosis	3.26e-05	0.000185	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—AKT1—atherosclerosis	3.05e-05	0.000173	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—AKT1—atherosclerosis	3.05e-05	0.000173	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ABCG1—atherosclerosis	2.89e-05	0.000164	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—AKT1—atherosclerosis	2.82e-05	0.00016	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—FABP4—atherosclerosis	2.71e-05	0.000154	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—LCAT—atherosclerosis	2.71e-05	0.000154	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—APOA4—atherosclerosis	2.66e-05	0.000151	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP7A1—atherosclerosis	2.62e-05	0.000148	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP27A1—atherosclerosis	2.42e-05	0.000137	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ALOX15—atherosclerosis	2.29e-05	0.00013	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	2.29e-05	0.00013	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—APOA2—atherosclerosis	2.29e-05	0.00013	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	2.29e-05	0.00013	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ABCG5—atherosclerosis	2.27e-05	0.000128	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—AKT1—atherosclerosis	2.25e-05	0.000128	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—LPA—atherosclerosis	2.19e-05	0.000124	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—AKT1—atherosclerosis	2.16e-05	0.000122	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—BGN—atherosclerosis	2.12e-05	0.00012	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—APOA5—atherosclerosis	2.1e-05	0.000119	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—AKT1—atherosclerosis	2.07e-05	0.000117	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	2.02e-05	0.000114	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.95e-05	0.000111	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—AKT1—atherosclerosis	1.82e-05	0.000103	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.75e-05	9.92e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—LIPC—atherosclerosis	1.74e-05	9.85e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—APOC3—atherosclerosis	1.73e-05	9.79e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—LDLR—atherosclerosis	1.72e-05	9.73e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CETP—atherosclerosis	1.68e-05	9.51e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.61e-05	9.1e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.52e-05	8.6e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.35e-05	7.66e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.16e-05	6.57e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—APOB—atherosclerosis	1.11e-05	6.3e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.08e-05	6.13e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—LPL—atherosclerosis	1.06e-05	6.01e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GPX1—atherosclerosis	1.03e-05	5.87e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CD36—atherosclerosis	1.01e-05	5.71e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—MTHFR—atherosclerosis	9.55e-06	5.41e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PPARA—atherosclerosis	9.37e-06	5.31e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AGT—atherosclerosis	9.07e-06	5.14e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—APOE—atherosclerosis	8.89e-06	5.04e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CAV1—atherosclerosis	8.81e-06	4.99e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—APOA1—atherosclerosis	8.79e-06	4.98e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PIK3CG—atherosclerosis	8.02e-06	4.55e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PPARG—atherosclerosis	7.74e-06	4.39e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—INS—atherosclerosis	7.6e-06	4.31e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ALB—atherosclerosis	6.96e-06	3.95e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NOS3—atherosclerosis	6.66e-06	3.78e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PTGS2—atherosclerosis	6.09e-06	3.45e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AKT1—atherosclerosis	3.06e-06	1.74e-05	CbGpPWpGaD
